Literature DB >> 9630255

The prevalence of Tourette syndrome in a mainstream school population.

A Mason1, S Banerjee, V Eapen, H Zeitlin, M M Robertson.   

Abstract

The aim of this study was to ascertain accurately the prevalence of Tourette syndrome (TS) in a mainstream school population. All year 9 pupils (aged 13 to 14 years) in a mainstream secondary school were investigated using a two-stage procedure. Standardized questionnaires were completed by parents, teachers, and pupils. Class observations were also carried out to identify tics. Those pupils identified as having tics underwent a semistructured interview to determine whether they had TS according to DSM-III-R criteria. Data were available from at least one source (parent, teacher, or self-reports) on 166 of the 167 pupils in the year. Five subjects were identified as having TS according to DSM-III-R criteria, yielding a prevalence estimate of 299 per 10,000 pupils in this age group. The results of this study suggest that TS in the community as a whole is more common and milder than those prevalence estimates and descriptions of the disorder based on TS encountered in secondary or tertiary health-care service settings.

Entities:  

Mesh:

Year:  1998        PMID: 9630255

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  20 in total

1.  Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder.

Authors:  Fiona C Crawford; Ghania Ait-Ghezala; Mark Morris; Maxine J Sutcliffe; Robert A Hauser; Archie A Silver; Michael J Mullan
Journal:  Hum Genet       Date:  2003-04-16       Impact factor: 4.132

2.  Attitude and knowledge of high school pupils towards adolescents with special needs (Tourette's syndrome).

Authors:  Uzi Brook; Mona Boaz
Journal:  Indian J Pediatr       Date:  2006-12       Impact factor: 1.967

3.  Identification of pyruvate kinase as an antigen associated with Tourette syndrome.

Authors:  Janice W Kansy; Liliya Katsovich; Kevin S McIver; Jennifer Pick; John B Zabriskie; Paul J Lombroso; James F Leckman; James A Bibb
Journal:  J Neuroimmunol       Date:  2006-10-02       Impact factor: 3.478

4.  Tourette syndrome and excitatory substances: is there a connection?

Authors:  Li-Ping Zou; Ying Wang; Li-Ping Zhang; Jian-Bo Zhao; Jin-Fang Lu; Qun Liu; Hang-Yan Wang
Journal:  Childs Nerv Syst       Date:  2010-11-06       Impact factor: 1.475

Review 5.  Cognitive-behavioral therapy for childhood repetitive behavior disorders: tic disorders and trichotillomania.

Authors:  Christopher A Flessner
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

Review 6.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 7.  [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

Authors:  K R Müller-Vahl
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

8.  Prevalence of tic disorders among schoolchildren in Warsaw, Poland.

Authors:  P Stefanoff; T Wolanczyk; A Gawrys; K Swirszcz; E Stefanoff; A Kaminska; M Lojewska-Bajbus; B Mazurek; A Majewska-Stefaniak; J Mikulska; A Brynska
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04       Impact factor: 4.785

9.  Levetiracetam as an alternative therapy for Tourette syndrome.

Authors:  M A Martínez-Granero; A García-Pérez; F Montañes
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

10.  Prevalence of tic disorders among primary school students in the city of Pavia, Italy.

Authors:  G Lanzi; C A Zambrino; C Termine; M Palestra; O Ferrari Ginevra; S Orcesi; P Manfredi; E Beghi
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.